Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies
In conclusion, this study highlights the potential of uPARAP as an innovative target for targeted treatments, such as novel antibody-drug conjugates in sarcoma.
Authors
- Pernille Barkholt (ORCID: https://orcid.org/0000-0002-3603-2915)
- Dominik Mumberg (ORCID: https://orcid.org/0000-0002-6670-1497)
- Kimberly Verbeeck
- Ulla Vanleeuw (ORCID: https://orcid.org/0009-0009-3296-3737)
- Lore De Cock (ORCID: https://orcid.org/0000-0002-9386-0688)
- Luna De Sutter (ORCID: https://orcid.org/0000-0001-9846-6631)
- Agnieszka Woźniak (ORCID: https://orcid.org/0000-0001-9726-144X)
- Carmel M. Lynch
- Che-Jui Lee
- Lars Henning Engelholm
- Chao-Chi Wang
- Patrick Schöffski
Institutions
- VIB-KU Leuven Center for Cancer Biology (BE)
- Ascendis Pharma (Denmark) (DK)
- KU Leuven (BE)
Publication Details
- Journal
- Translational Oncology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1016/j.tranon.2026.102708
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00